Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immunocore Holdings (IMCR) Current Assets: 2022-2024

Historic Current Assets for Immunocore Holdings (IMCR) over the last 3 years, with Dec 2024 value amounting to $929.9 million.

  • Immunocore Holdings' Current Assets rose 1.68% to $1.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 billion, marking a year-over-year increase of 1.68%. This contributed to the annual value of $929.9 million for FY2024, which is 75.84% up from last year.
  • Latest data reveals that Immunocore Holdings reported Current Assets of $929.9 million as of FY2024, which was up 75.84% from $528.8 million recorded in FY2023.
  • In the past 5 years, Immunocore Holdings' Current Assets ranged from a high of $929.9 million in FY2024 and a low of $474.0 million during FY2022.
  • Its 3-year average for Current Assets is $644.2 million, with a median of $528.8 million in 2023.
  • Data for Immunocore Holdings' Current Assets shows a peak YoY spiked of 75.84% (in 2024) over the last 5 years.
  • Immunocore Holdings' Current Assets (Yearly) stood at $474.0 million in 2022, then increased by 11.57% to $528.8 million in 2023, then surged by 75.84% to $929.9 million in 2024.